TROXACITABINE
|
|
TROXACITABINE Eigenschaften
- Schmelzpunkt:
- 176-177°
- alpha
- D25 -38.33° (c = 0.43 in MeOH).
- Siedepunkt:
- 422.5±55.0 °C(Predicted)
- Dichte
- 1.71±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C(protect from light)
- L?slichkeit
- DMSO (Slightly), Methanol (Slightly)
- Aggregatzustand
- Solid
- pka
- 14.83±0.10(Predicted)
- Farbe
- White to Off-White
- Stabilit?t:
- Hygroscopic
Sicherheit
TROXACITABINE Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Troxacitabine is a nucleoside analogue with potential anticancer activity. Troxacitabine have been studied in patients with refractory lymphoproliferative diseases.TROXACITABINE Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
TROXACITABINE Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 89)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Standardpharm Co. Ltd. | 86-714-3992388 |
overseasales1@yongstandards.com | United States | 14332 | 58 |
CONIER CHEM AND PHARMA LIMITED | +8618523575427 |
sales@conier.com | China | 49374 | 58 |
career henan chemical co | +86-0371-86658258 +8613203830695 |
factory@coreychem.com | China | 29811 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 |
marketing@targetmol.com | United States | 32080 | 58 |
Hubei Ipure Biology Co., Ltd | +8613367258412 |
ada@ipurechemical.com | China | 10319 | 58 |
Hangzhou Huarong Pharm Co., Ltd. | 571-86758373 +8613588754946 |
sales@huarongpharm.com | CHINA | 3148 | 58 |
NewCan Biotech Limited | +86-0571-86912261 +8613735419629 |
sales@newcanbio.com | China | 9980 | 58 |
Wuhan Topule Biopharmaceutical Co., Ltd | +8618327326525 |
masar@topule.com | China | 8467 | 58 |
LEAPCHEM CO., LTD. | +86-852-30606658 |
market18@leapchem.com | China | 43340 | 58 |
Zhengzhou Chemprize Biotech Co., Ltd. | +86-86-0371-56768238 +8615981919713 |
sales@chemprize.com | China | 297 | 58 |
145918-75-8()Verwandte Suche:
- TROXACITABINE
- TROXACITABINE,2(1H)-PYRIMIDINONE, 4-AMINO-1-(2-(HYDROXYMETHYL)-1,3-DIOXOLAN-4-YL)-, (2S-CIS)-
- 4-Amino-1-[(2S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]pyrimidin-2-one
- (-)-Bch 204
- (-)-Occc
- 2(1H)-Pyrimidinone, 4-amino-1-((2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl)-
- 2(1H)-Pyrimidinone, 4-amino-1-(-2-(hydroxymethyl)-1,3-dioxolan-4-yl)-, (2S-cis)-
- Bch 4556
- L-Oddc
- Troxatyl
- Troxacitabine (SGX-145)
- SPD 758
- α-L-Dioxolane-C
- Lamivudine Impurity I
- 4-amino-1-((2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl)pyrimidin-2(1H)-one
- CS-150
- Lamivudine Impurity I (Troxacitabine)
- 4-amino-1-[(2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]-1,2-dihydropyrimidin-2-one
- Lamivudine EP Impurity I
- Lamivudine EP Impurity I (Troxacitabine)
- Troxacitabine(BCH4556)
- 4-amino-1-((2RS,4RS)-2-(hydroxymethyl)-1,3-dioxolan-4-yl)pyrimidin-2(1H)-one
- 145918-75-8